Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Applied Health Economics and Health Policy
Published in: Applied Health Economics and Health Policy 1/2017

01-02-2017 | Original Research Article

Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers

Authors: Elias Asfaw Zegeye, Josue Mbonigaba, Sylvia Blanche Kaye, Thomas Wilkinson

Published in: Applied Health Economics and Health Policy | Issue 1/2017

Login to get access

Abstract

Background

Globally, economic evaluation (EE) is increasingly being considered as a critical tool for allocating scarce healthcare resources. However, such considerations are less documented in low-income countries, such as in Ethiopia. In particular, to date there has been no assessment conducted to evaluate the perception and practice of and barriers to health EE.

Objective

This paper assesses the use and perceptions of EE in healthcare decision-making processes in Ethiopia.

Methods

In-depth interview sessions with decision makers/healthcare managers and program coordinators across six regional health bureaus were conducted. A qualitative analysis approach was conducted on three thematic areas.

Results

A total of 57 decision makers/healthcare managers were interviewed from all tiers of the health sector in Ethiopia, ranging from the Federal Ministry of Health down to the lower levels of the health facility pyramid. At the high-level healthcare decision-making tier, only 56 % of those interviewed showed a good understanding of EE when explaining in terms of cost and consequences of alternative courses of action and value for money. From the specific program perspective, 50 % of the prevention of mother-to-child transmission of HIV/AIDS program coordinators indicated the relevance of EE to program planning and decision making. These respondents reported a limited application of costing studies on the HIV/AIDS prevention and control program, which were most commonly used during annual planning and budgeting.

Conclusion

The study uncovered three important barriers to growth of EE in Ethiopia: a lack of awareness, a lack of expertise and skill, and the traditional decision-making culture.
Appendix
Available only for authorised users
Literature
1.
O’Brien B. Principles of economic evaluation for health care programs. J Rheumatol. 1995;22(7):1399–402.PubMed
2.
Eddama O, Coast J. A systematic review of the use of economic evaluation in local decision-making. Health Policy. 2008;86(2–3):129–41.CrossRefPubMed
3.
Ross J. The use of economic evaluation in health care: Australian decision makers’ perceptions. Health Policy. 1995;31(2):103–10.CrossRefPubMed
4.
Bryan S, Williams I, McIver S. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals. Health Economics. 2007;16(2):179–93.CrossRefPubMed
5.
Brousselle A, Lessard C. Economic evaluation to inform health care decision-making: promise, pitfalls and a proposal for an alternative path. Soc Sci Med. 2011;72(6):832–9.CrossRefPubMed
6.
Drummond M, Brandt A, Luce B, Rovira J. Standardizing methodologies for economic evaluation in health care: practice, problems, and potential. Int J Technol Assess Health Care. 1993;9(01):26–36.CrossRefPubMed
7.
Drummond M. Economic evaluation and the rational diffusion and use of health technology. Health Policy. 1987;7(3):309–24.CrossRefPubMed
8.
Yothasamut J, Tantivess S, Teerawattananon Y. Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable? Value Health. 2009;12(SUPPL. 3):S26–30.CrossRefPubMed
9.
Gavaza P, Rascati KL, Oladapo AO, Khoza S. The state of health economic evaluation research in Nigeria. Pharmacoeconomics. 2010;28(7):539–53.PubMed
10.
Gavaza P, Rascati KL, Oladapo AO, Khoza S. PHP46 The state of health economic evaluation in South Africa: a systematic review. Value Health. 2011;14(3):A19.CrossRef
11.
Gavaza P, Rascati KL, Lawson KA, Brown CM, Mann T. PHP48 The state of health economics and pharmacoeconomics evaluation research in Zimbabwe. Value Health. 2008;11(3):A43.CrossRef
12.
Gavaza P, Rascati K, Oladapo AO, Khoza S. PHP80 The state of health economics and pharmaceoconomics evaluation research in Nigeria: a systematic review. Value Health. 2010;13(3):A96.CrossRef
13.
Lessard C, Contandriopoulos AP, Beaulieu MD. The role (or not) of economic evaluation at the micro level: can Bourdieu’s theory provide a way forward for clinical decision-making? Soc Sci Med. 2010;70(12):1948–56.CrossRefPubMed
14.
Williams I, McIver S, Moore D, Bryan S. The use of economic evaluations in NHS decision-making: a review and empirical investigation. Clin Gov Int J. 2008;13(3).
15.
Hoffmann C, von der Schulenburg JMG. The influence of economic evaluation studies on decision making: a European survey. Health Policy. 2000;52(3):179–92.CrossRefPubMed
16.
Merlo G, Page K, Ratcliffe J, Halton K, Graves N. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake. Appl Health Econ Health Policy. 2015;13(3):303–9.CrossRefPubMed
17.
Fasawe O, Avila C, Shaffer N, Schouten E, Chimbwandira F, Hoos D, et al. Cost-effectiveness analysis of option B+ for HIV prevention and treatment of mothers and children in Malawi. PloS one. 2013;8(3):e57778.CrossRefPubMedPubMedCentral
18.
Shah M, Johns B, Abimiku AL, Walker DG. Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting. Acquir Immune Defic Syndr. 2011;25(8):1093–102.
19.
Söderlund N, Zwi K, Kinghorn A, Gray G. Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. BMJ. 1999;318(7199):1650–6.CrossRefPubMedPubMedCentral
20.
Ciaranello AL, Perez F, Maruva M, Chu J, Engelsmann B, Keatinge J, et al. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers. PloS One. 2011;6(6):e20224.CrossRefPubMedPubMedCentral
21.
Kuznik A, Lamorde M, Hermans S, Castelnuovo B, Auerbach B, Semeere A, et al. Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda. Bull World Health Organ. 2012;90(8):595–603.CrossRefPubMedPubMedCentral
22.
Ministry of Finance and Economic Development (MoFED). The Federal Democratic Republic of Ethiopia: Growth and Transformation Plan (GTP) 2010/11–2014/15. Addis Ababa: Ethiopia Ministry of Finance and Economic Development; 2010.
23.
Federal Ministry of Health (FMOH). Health Sector Transformation Plan (HSTP) 2015/16–2019/20. Addis Ababa: Ethiopia Federal Ministry of Health; 2015.
24.
Federal Ministry of Health (FMOH). Health Sector Development Programme (HSDP IV) 2010/11–2014/15. Addis Ababa: Ethiopia Federal Ministry of Health; 2010.
25.
World Health Orgnization. WHO. Geneva: World Health Statistics, World Health Organization; 2014.
26.
Wang H, Ramana GNV. Ethiopia—Universal health coverage for inclusive and sustainable development: country summary report: Washington DC; 2014.
27.
Koblinsky M, Tain F, Gaym A, Karim A, Carnell M, Tesfaye S. Responding to the maternal health care challenge: the Ethiopian Health Extension Program. Ethiop J Health Dev. 2010;24(1).
28.
Federal Ministry of Health (FMOH). Health Management Information System (HMIS) Information User Guide. Addis Ababa: Ethiopia Federal Ministry of Health; 2013.
29.
30.
Federal Ministry of Health (FMOH). Ethiopia’s Fifth National Health Accounts 2010/2011. Addis Ababa: Ethiopia Federal Ministry of Health; 2014.
31.
Organisation of African Unity (OAU). Abuja declaration on HIV/AIDS, tuberculosis, and other related infectious diseases. OAU/SPS/ Abuja/3: New York. United Nations; 2001.
32.
Bikilla AD, Jerene D, Robberstad B, Lindtjorn B. Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia. Cost Eff Resour Alloc. 2009;7(6):1.
33.
Kombe G, Galaty D, Gadhia R, Decker C. Human and financial resource requirements for scaling up HIV/AIDS services in Ethiopia. Bethesda MD: The Partners for Health Reform plus Project Abt Associates Inc; 2004.
34.
Johns B, Asfaw E, Wong W, Bekele A, Minior T, Kebede A, et al. Assessing the costs and effects of antiretroviral therapy task shifting from physicians to other health professionals in Ethiopia. Acquir Immune Defic Syndr. 2014;65(4):140–7.CrossRef
35.
36.
Bikilla AD, Jerene D, Robberstad B, Lindtjørn B. Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia. Cost Eff Resour Alloc. 2009;7(13):1.
37.
Federal HIV/AIDS Prevention and Control Office (FHAPCO). Facility-based anti-retroviral treatment costing study in Ethiopia. Addis Ababa: Ethiopia Federal HIV/AIDS Prevention and Control Office/Ethiopia Federal Ministry of Health; 2012.
38.
Creswell JW, Clark VL. Designing and conducting mixed method research. 2nd ed. USA: SAGE Publications Inc; 2011.
39.
Bryman A. Social research methods. 4th ed. New York: Oxford University Press; 2012.
40.
Coast J. The appropriate uses of qualitative methods in health economics. Health Econ. 1999;8(4):345–53.CrossRefPubMed
41.
Ethiopian Public Health Institute (EPHI). Report on the 2012 round Antenatal case based sentinel surveillance in Ethiopia. Addis Ababa: Ethiopian Public Health Institute; 2014.
42.
Patton MQ. How to use qualitative methods in evaluation. SAGE Publications Inc; 1987.
43.
Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart GL. Methods for the economic evaluation of health care programs. 3rd ed. New York: Oxford University Press; 2005.
44.
Sax S. Health care choices and the public purse. Sydney: Allen and Unwin; 1990.
45.
Federal Ministry of Health (FMOH). Human Resource Development and Management directorate. Human resource directive and incentive package document 200-8/3/6. Addis Ababa: Ethiopian Federal Ministry of Health; 2014.
46.
Morrison S, Brundage S. Advancing health in Ethiopia with fewer resource, an uncertian GHI strategy, and vulnerabilities on the ground. Washington DC: Centre for Strategic and International Studies; 2012.
47.
Resch S, Ryckman T, Hecht R. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries. Lancet Glob Health. 2015;3(1):e52–61.CrossRefPubMed
48.
Johnnesson M. Economic evaluation of health care and policymaking. Health Policy. 1995;33(3):179–90.CrossRef
49.
Hoffmann C, Stoykova BA, Nixon J, Glanville JM, Misso K, Drummond MF. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health. 2002;5(2):71–8.CrossRefPubMed
50.
Eddama O, Coast J. Use of economic evaluation in local health care decision-making in England: a qualitative investigation. Health Policy. 2009;89(3):261–70.CrossRefPubMed
51.
Drummond M. Economic evaluation in health care: is it really useful or are we just kidding ourselves? Aust Econ Rev. 2004;37(1):3–11.CrossRef
52.
Wiseman V, Mitton C, Doyle-Waters MM, Drake T, Conteh L, Newall AT, et al. Using economic evidence to set healthcare priorities in low-income and lower-middle-income countries: a systematic review of methodological frameworks. Health Econ. 2016;25(S1):140–61.CrossRefPubMedPubMedCentral
53.
Greco G, Lorgelly P, Yamabhai I. Outcomes in economic evaluations of public health interventions in low-and middle-income countries: health, capabilities and subjective wellbeing. Health Econ. 2016;25(S1):83–94.CrossRefPubMedPubMedCentral
Metadata
Title
Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers
Authors
Elias Asfaw Zegeye
Josue Mbonigaba
Sylvia Blanche Kaye
Thomas Wilkinson
Publication date
01-02-2017
Publisher
Springer International Publishing
Published in
Applied Health Economics and Health Policy / Issue 1/2017
Print ISSN: 1175-5652
Electronic ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-016-0280-z

Other articles of this Issue 1/2017

Applied Health Economics and Health Policy 1/2017 Go to the issue

Review Article

Health State Utility Values for Age-Related Macular Degeneration: Review and Advice

Original Research Article

Panobinostat Plus Bortezomib Versus Lenalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Treatment Comparison of Survival Outcomes using Patient-level Data

Original Research Article

Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease

Current Opinion

The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements

Original Research Article

Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications

Review Article

Economic Crisis, Austerity Policies, Health and Fairness: Lessons Learned in Spain